https://data.archives-ouvertes.fr/author/997598

https://data.archives-ouvertes.fr/author/997598

http://xmlns.com/foaf/0.1/topic_interest Dyslipidemia
http://xmlns.com/foaf/0.1/topic_interest Visceral fat
http://xmlns.com/foaf/0.1/topic_interest Inhibition
http://xmlns.com/foaf/0.1/topic_interest Hypercortisolism
http://xmlns.com/foaf/0.1/topic_interest Inhibiteurs mTOR
http://xmlns.com/foaf/0.1/topic_interest Diabetes
http://xmlns.com/foaf/0.1/mbox_sha1sum 00543880c1e6b226a2a7d647c955e0f4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://xmlns.com/foaf/0.1/Person
http://xmlns.com/foaf/0.1/topic_interest Rhabdomyolysis
http://xmlns.com/foaf/0.1/firstName Benjamin
http://xmlns.com/foaf/0.1/topic_interest Density-Lipoprotein Receptor
http://xmlns.com/foaf/0.1/topic_interest Apoc-I
http://xmlns.com/foaf/0.1/topic_interest MTOR inhibitors
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.aen
http://xmlns.com/foaf/0.1/topic_interest Transgenic Mice
http://xmlns.com/foaf/0.1/topic_interest Diabète
http://xmlns.com/foaf/0.1/topic_interest Diabetic dyslipidemia
http://xmlns.com/foaf/0.1/name Benjamin Bouillet
http://xmlns.com/foaf/0.1/topic_interest Diabète de type 2
http://xmlns.com/foaf/0.1/topic_interest Diabetes mellitus
http://xmlns.com/foaf/0.1/topic_interest Type 2 diabetes
http://xmlns.com/foaf/0.1/topic_interest Pituitary diseases
http://xmlns.com/foaf/0.1/topic_interest Apolipoprotein C1
http://xmlns.com/foaf/0.1/topic_interest Healing
http://xmlns.com/foaf/0.1/topic_interest Triglycerides
http://xmlns.com/foaf/0.1/topic_interest GLP1 agonist
http://xmlns.com/foaf/0.1/topic_interest Liver fat content
http://xmlns.com/foaf/0.1/topic_interest Malnutrition
http://xmlns.com/foaf/0.1/topic_interest Hepatic Steatosis
http://xmlns.com/foaf/0.1/topic_interest Kinetics
http://xmlns.com/foaf/0.1/topic_interest Diabetic foot ulcer
http://xmlns.com/foaf/0.1/topic_interest Insulin-Resistance
http://xmlns.com/foaf/0.1/topic_interest ApoB48
http://xmlns.com/foaf/0.1/topic_interest Overexpression
http://xmlns.com/foaf/0.1/topic_interest Vldl
http://xmlns.com/foaf/0.1/topic_interest Hyperlipidemias
http://xmlns.com/foaf/0.1/topic_interest Steatosis
http://xmlns.com/foaf/0.1/topic_interest Patients
http://xmlns.com/foaf/0.1/topic_interest Protein
http://xmlns.com/foaf/0.1/familyName Bouillet
http://xmlns.com/foaf/0.1/topic_interest Dyslipidémie
http://xmlns.com/foaf/0.1/topic_interest Lipides
http://xmlns.com/foaf/0.1/topic_interest IGF1
http://xmlns.com/foaf/0.1/topic_interest Liraglutide
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.em
http://xmlns.com/foaf/0.1/topic_interest Hyperlipidemia
http://xmlns.com/foaf/0.1/topic_interest Tissu Adipeux
http://xmlns.com/foaf/0.1/topic_interest Metyrapone
http://xmlns.com/foaf/0.1/topic_interest Non-alcoholic fatty liver disease
http://xmlns.com/foaf/0.1/topic_interest Postprandial hyperlipidemia

Télécharger au format